News

Research led by the Department of General and Visceral Surgery, Faculty of Medicine, University of Freiburg, Germany has ...
Gallbladder cancer, a rare malignancy affecting the organ storing bile, often presents without early symptoms, leading to ...
Neighbors organized a car wash fundraiser to support 9-year-old Logan Coyle, a local boy who has faced unimaginable medical ...
“By uncovering specific genetic vulnerabilities like the CDS1 and CDS2 relationship, we’re opening the door to new therapies ...
Cambridge-driven research has identified a novel target with therapeutic potential for metastatic eye melanoma — an ...
AstraZeneca secures EU approval for Imfinzi in muscle-invasive bladder cancer, expanding its cancer treatment portfolio.
Metformin use may enhance progression-free survival (PFS) in patients receiving first-line systemic therapy for patients with ...
The approval comes amid speculation that the big pharma company may switch its UK stock market listing to the US.
The combination of cabozantinib and atezolizumab appeared more effective than switching ARPI therapy in patients with mCRPC and extrapelvic soft-tissue metastases.
Prostate cancer is a significant health concern for men globally, with rising incidence and mortality rates. Early detection ...
According to the latest study from BCC Research, "Global Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic ...
The latest research published in Genes & Diseases unveils groundbreaking insights into the role of the aging process and the ...